Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. The company is headquartered in Woburn, Massachusetts. The Company’s Abpro’s DiversImmune platform helps to generate monoclonal antibodies. The Diversimmune platform combines the nano-immunology, next-generation sequencing, engineering and bioinformatics to create monoclonal antibodies against traditionally difficult targets. The Company’s therapies to treat cancer, eye, autoimmune, infectious diseases and other areas.
ABP stock price ended at $0 on 星期四, after dropping NaN%
On the latest trading day Aug 06, 2026, the stock price of ABP fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for ABP decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.